Bolt Projects Holdings, Inc. (BSLK)
NASDAQ: BSLK · Real-Time Price · USD
3.850
-0.020 (-0.52%)
At close: Sep 11, 2025, 4:00 PM EDT
3.840
-0.010 (-0.26%)
After-hours: Sep 11, 2025, 4:14 PM EDT
Company Description
Bolt Projects Holdings, Inc. develops and produces biomaterials products in the United States.
It offers b-silk and xl-silk that are biodegradable and vegan protein polymer and replacement for silicone elastomers in beauty and personal care.
The company was founded in 2009 and is based in San Francisco, California.
Bolt Projects Holdings, Inc.
| Country | United States |
| Founded | 2009 |
| Industry | Specialty Chemicals |
| Sector | Materials |
| Employees | 14 |
| CEO | Daniel Widmaier |
Contact Details
Address: 2261 Market Street, Suite 5447 San Francisco, California 94114 United States | |
| Phone | 415 325 5912 |
| Website | boltthreads.com |
Stock Details
| Ticker Symbol | BSLK |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001841125 |
| CUSIP Number | 09769B107 |
| ISIN Number | US09769B2060 |
| Employer ID | 86-1256660 |
| SIC Code | 2860 |
Key Executives
| Name | Position |
|---|---|
| Daniel Widmaier Ph.D. | Co-Founder, Chairman and Chief Executive Officer |
| Cintia Nardi | President |
| David N. Breslauer Ph.D. | Co-Founder, Chief Technology Officer, Chief Product Officer and Director |
| Randy Befumo CFA | Interim Chief Financial Officer |
| Paul Slattery | General Counsel and Secretary |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Sep 3, 2025 | 424B3 | Prospectus |
| Sep 2, 2025 | EFFECT | Notice of Effectiveness |
| Sep 2, 2025 | SCHEDULE 13G | Filing |
| Sep 2, 2025 | 424B3 | Prospectus |
| Sep 2, 2025 | 424B3 | Prospectus |
| Aug 29, 2025 | D | Notice of Exempt Offering of Securities |
| Aug 29, 2025 | 8-K | Current Report |
| Aug 26, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Aug 22, 2025 | S-1 | General form for registration of securities under the Securities Act of 1933 |
| Aug 20, 2025 | SCHEDULE 13D/A | Filing |